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A simple and inexpensive sample preparation method based on solvent extraction, followed by low
temperature cleanup, was demonstrated to be applicable for the determination of avermectin and
milbemycin residues in bovine muscle by liquid chromatography-tandem mass spectrometry (LC-MS/
MS) and liquid chromatography with ﬂuorescence (LC-FL) detection. The analytical methodology was
validated according to the Commission Decision 2002/657/EC, using LC-MS/MS for conﬁrmatory and LC-
FL for quantitative purposes. Mean recovery was between 88.9 and 100.7% in three distinct concentra-
tions. The coefﬁcient of variation for repeatability and within-laboratory reproducibility ranged from
0.78 to 5.1% and from 0.28 to 9.0%, respectively. Method precision led to satisfactory values of decision
limits (CCa) and detection capabilities (CCb). The proposed method has been applied in the Brazilian
National Residue Control Plan since 2010 for the determination of avermectins and milbemycin residues
in bovine muscle samples. A total of 760 samples were analyzed and none of them presented residues at
concentrations above the permitted levels established by the more recently applied directives.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Antiparasitic drugs are used worldwide for the treatment and
prevention of parasitic diseases in food producing animals, and are
particularly important for cattle raising in tropical regions where
cattle graze on rangelands and are intensively affected by both endo
and ectoparasitosis (Phillips, 2010). In Brazil, which is the world’s
largest exporter of cattle meat (ABIEC, 2011), the avermectins iver-
mectin (IVR), abamectin (ABA), doramectin (DOR), eprinomectin
(EPR), and the milbemycin moxidectin (MOX) are among the most
common antiparasitic drugs administered to cattle, representing
more than 44% of the total veterinary antiparasitic compounds
commercialized in the country (SINDAN, 2012). This preference is
probably a consequence of their extended endectocide activity and
due to the slow elimination rates of these compounds in cattle.
However, the longer persistence of these compounds in the cattle
bodymayalso lead to the presence of residues in foodstuff of animal
origin, at levels above the maximum residue limits (MRL) estab-
lished by different countries, causing undesirables risks of public
health associated with their consumption.sam).
r OA license.In early 2010, a special attention was given to the occurrence of
IVR residues in corned beef and similar products exported from
Brazil to United States (US) and European Community (EC) at levels
above the US tolerance of 10 mg kg1 (USDA-FAS, 2010). At that
time, the EC had not established MRL for IVR in bovine muscle,
however, due to this occurrence, an action level of 30 mg kg1 was
adopted for non-injection site samples (Kaufmann, Butcher, Maden,
Walker, & Widmer, 2011; RASFF, 2011). Additionally, it was rec-
ommended a provisional MRL of 1300 mg kg1 for injection site
samples (EMA, 2011). Until early 2010, no MRL was established by
Brazilian legislation for avermectin residues in muscle samples
from both injection and non-injection sites. Although the expor-
tation of these beef products was temporarily suspended by the
Brazilian Ministry of Agriculture in May 2010, others 19 occur-
rences of IVR residues in beef products imported from Brazil were
registered by the EC in 2010 (RASFF, 2011), and others 22 violations
detected by the United States Food Safety and Inspection Service
(FSIS) between March and June 2010 (USDA, 2010). In June 2010,
a series of corrective actions were introduced by the Brazilian
government to solve such problems, within which the inclusion of
avermectins analysis in bovine muscle in the Brazilian National
Residue Control Plan (NRCP), following the same concern of NRCP
expansion and analytical coverage proposed elsewhere (Mauricio,
Lins, & Alvarenga, 2009).
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NRCP in liver and milk samples for more than thirteen years
through LC-FL after derivatization with 1-methylimidazole/acetic
anhydride and, more recently, through LC-MS/MS, using an atmo-
spheric pressure chemical ionization (APCI) interface. In both
methods, the residues are extracted with acetonitrile (ACN) and
puriﬁed by solid phase extraction (SPE) cartridges with C18 before
the chromatographic analyses, similarly to those methods reported
in the literature for the same purposes in milk (Souza, Lima,
Teodoro, & Junqueira, 2007; Turnipseed, Roybal, Andersen, &
Kuck, 2005) and liver (Ali, Sun, McLeroy, & Phillippo, 2000; Souza
et al., 2003) samples. Recently, we have applied an alternative
sample preparation based on liquideliquid extraction with low
temperature puriﬁcation (LTP) for avermectins analysis in milk
(Rübensam, Barreto, Hoff, Kist, & Pizzolato, 2011). Methods based
on this cleanup technique have been used predominantly for
pesticides residues analysis in different matrices (Goulart, Queiroz,
Neves, & Queiroz, 2008; Lentza-Rizos, Avramides, & Frédérique,
2001; Pinho, Neves, Queiroz, & Silvério, 2010a, 2010b). In these
procedures, generally the extract is obtained adding organic solvent
to the sample, and the cleanup is performed by freezing this extract
at 20 C. Under this condition, the interfering compounds are
frozen, whereas analytes remains in the liquid phase and are
subsequently separated. For avermectins analysis, additional
procedures were introduced in this method, such as sodium chlo-
ride additions (salting-out effect) and extract centrifugation, in
order to obtain an extract clear and relatively free of interfering
compounds (eg. polar proteins). In its ﬁrst application for veteri-
nary drugs analysis, this method proved to be simple, easy, inex-
pensive, and adequate alternative for high-throughput analysis of
a large number of samples per day. Based on these issues and
considering the urgency for method validation, the application of
LTP was extended to the extraction procedure of avermectins and
milbemycin residues in bovine muscle samples.
The goal of thepresentworkwas to report the applicationof LTP in
the analysis of avermectins and milbemycin residues in bovine
muscle by LC-MS/MS and LC-FL methods validated according to the
Decision 2002/657/EC (EC, 2002). The practical issues for the imple-
mentation of the proposed methods in the Brazilian NRCP are also
addressed. To our knowledge, this is the ﬁrst application of an LTP
cleanup-based method for avermectins analysis in bovine muscle.2. Material and methods
2.1. Chemicals
Ivermectin, eprinomectin, emamectin benzoate (EMA), dor-
amectin, abamectin, and moxidectin standards with purity higher
than 81% were purchased from SigmaeAldrich (St. Louis, MO, USA).Table 1
Mass spectrometry settings for MS/MS analysis of avermectins and milbemycin in positi
Analytes RT (min) Molecular ion Precursor ion (m/z) P
ABA 9.6 [M þ NH4]þ 890.4 3
5
DOR 10.5 [M þ NH4]þ 916.5 3
5
EPR 8.7 [M þ H]þ 914.5 4
1
EMA 8.4 [M þ H]þ 886.1 1
IVR 12.0 [M þ NH4]þ 892.5 3
5
MOX 10.9 [M þ H]þ 640.4 5
4
a Most abundant fragment ion; (RT) Retention time.ACN and acetic acid with HPLC grade were from J.T. Baker (Phil-
lipsburg, NJ, USA). Ammonium acetate was obtained from
Mallinckrodt-Baker (Phillipsburg, NJ, USA). 1-Methylimidazole and
triﬂuoroacetic anhydride with derivatization grade were obtained
from Vetec (Rio de Janeiro, Brazil).
Individual stock solutions of 1.0 mg mL1 were prepared by
dissolving 10mg of the solid standard in 10mL of ACN. Theworking
solutionwas prepared by combining aliquots of each stock solution
in ACN to obtain a ﬁnal concentration of 1 mg mL1 for ABA, IVR and
MOX, 1.5 mg mL1 for DOR and 2.0 mg mL1 for EPR in acetonitrile.
EMA was used as surrogate standard and its working solution was
prepared and stored in separate ﬂask at 1.0 mg mL1 in ACN. All the
standard solutions were stored at - 20 C in a polypropylene tube.
2.2. LC-MS/MS analysis
LC-MS/MS analyses were performed on an Agilent 1100 series
LC system (Santa Clara, CA, USA) equipped with a binary pump,
a vacuum degasser, and an autosampler, coupled to an API 5000
triple quadrupole tandem mass spectrometer (Applied Biosystems,
Foster City, CA, USA) equipped with an electrospray ionization
source (ESI), operating in the positive mode. The ionspray voltage
and the source temperature were set at w4500 V and 500 C,
respectively. The ions were monitored using the multiple reaction-
monitoring (MRM) mode for two transitions with a dwell time of
100 ms. The tandem MS conditions are reported in the Table 1.
Separation was performed on a Phenomenex Luna C18 column
(150 mm  2.1 mm, i.d., 5 mm), preceded by a guard column
(4 mm  3 mm i.d.) with the same packing material (Phenomenex,
Torrance, CA, USA), using a mobile phase consisting of water (A),
ACN (B), and 50mM ammonium acetate buffer pH 5 (C), in gradient
mode, at ﬂow rate of 0.2 mL min1. The gradient was programmed
to start with a mobile phase composition of 50% A, 45% B, and 5% C,
and then programmed to 95% B and 5% C after 2 min. This
composition was maintained for 15 min before returning to the
start condition. The injection volume was 10 mL. A divert valve was
used to direct the eluent ﬂow to waste for the ﬁrst 3.5 min to help
remove any matrix impurities from entering the MS/MS.
2.3. LC-FL analysis
LC-FL analyses were performed on a Shimadzu LC-20AT system
(Kyoto, Japan) equipped with a SIL-HTc autosampler, and an RF-10
AXL ﬂuorescence detector operating at 365 nm (excitation) and
470 nm (emission). The separation was achieved on a Phenomenex
Luna C18 column (50 mm 2.1 mm, i.d., 5 mm) preceded by a guard
column (4 mm  3 mm i.d.) with the same packing material
(Phenomenex, Torrence, CA, US), using a mobile phase consisted of
water (A) and ACN (B), in gradient mode, at ﬂow rate ofve mode.
roduct ions (m/z) Declustering potential (V) Collision energy (eV)
05.6a 96 33
67.3 96 35
31.3a 66 35
93.3 66 19
68.2 106 17
86.1a 76 29
58.0a 76 57
07.3a 71 33
69.4 71 21
28.2a 30 9
98.3 28 17
Fig. 1. Effects of solvent-sample ratio and the contact time on the compounds
extraction.
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programmed to 5% A and 95% B after 5 min. This composition was
maintained for 25 min before returning to the start conditions.
For LC-FL direct detection, the analytes (500 mL of the
extract þ 290 mL of ACN) were previously derivatized with
1-methylimidazole (80 mL), triﬂuoroacetic anhydride (80 mL) and
acetic acid (50 mL), at 64 C in a heating block for 20 min. After this,
the derivatized solution was left at room temperature for 10 min
and then analyzed (5 mL) by LC-FL.
2.4. Sample preparation
Samples of bovine muscle (from different anatomical locations,
excluding injection sites) were obtained from distinct regions of
Brazil, according to the sampling program established in the Bra-
zilian NRCP, by the Brazilian Federal Inspection Service, from July
2010 to December 2011, resulting in 760 samples. The samples with
no residues of avermectins and milbemycin were used for calibra-
tion, quality control (QC), and validation purposes. Matrix-matched
calibration curves were prepared in triplicate, adding 0, 2.5, 12.5,
25, 50, 75, and 100 mL of standard working solution with 25 mL of
surrogate to 5 g of blank samples. QC samples were prepared at two
distinct levels, one at MRL and the other at an arbitrary concen-
tration between the linear range of the calibration curve.
Sample extraction was carried out as described elsewhere
(Rübensam et al., 2011), adapted for tissue matrix. An aliquot of 5 g
of ﬁnely chopped sample was placed into a 50 mL polypropylene
tube. Samples were fortiﬁed with the analytes and/or the surrogate
standard and were homogenized after adding 2.5 mL of ultra-pure
water. Two aliquots of 2.5 mL and one of 5 mL of ACN were
successively added to the samples with 10 s of mixing on a vortex
between each solvent addition. These mixtures were shaken on
a shaking table, at 180 rotations per minute, for 20 min. Approxi-
mately 2 g of sodium chloride were added to each sample, followed
by homogenization for 5 min, and subsequent centrifugation for
10 min at 2200g. The top layer was transferred to a 15 mL poly-
propylene centrifuge tube and stored in the freezer at 20 C for
12 h, in order to perform LTP. After this time, the liquid extract was
transferred to a 50 mL centrifuge tube, evaporated to dryness at
40e45 C under a gently nitrogen ﬂow, and reconstitutedwith 1mL
of ACN. The ﬁnal extract was divided in two aliquots, one (500 mL)
was reserved for LC-FL analysis after derivatization, and the other
for LC-MS/MS analysis.
The optimization of sample extraction and cleanup was carried
out using different solvent-samples ratios (from 1:1 to 3:1), varying
the contact time between sample and solvent (from 0 to 30 min),
and varying the freezing time in the LTP step (from 1 h to 24 h).
2.5. Validation procedure
The validation of the methods using LC-MS/MS and LC-FL was
carried out according to the European Commission decision 2002/
657/EC (EC, 2002) for qualitative conﬁrmation and quantitative
screening purposes, respectively. The performance characteristics
evaluated were selectivity, speciﬁcity, CCa (only for LC-MS/MS),
CCb, precision (only for LC-FL), recovery (R), and stability. In addi-
tion, linearity and the detection and quantiﬁcation limits were also
determined for LC-FL method.
Analyte conﬁrmation was performed based on the ion ratio
criteria established in the 2002/657/EC guide for LC-MS/MS, in
which the relative intensity of two transitions for each analyte shall
correspond to those of the calibration standard, associated with
analyte retention time. Selectivity and speciﬁcity were evaluated
analyzing twenty different blank muscle samples with and without
addition of analytes, and analyzing samples spiked with thestandard solutions at concentrations corresponding to validation
levels (VL) of 10 mg kg1 for ABA, IVR, and MOX, 15 mg kg1 for DOR,
and 20 mg kg1 for EPR. EMAwas used as surrogate at 5 mg kg1. For
the calculation of method precision (in terms of intra- and inter-day
precision, expressed as coefﬁcient of variation CV%) and recovery,
three lots of eighteen blank samples fortiﬁed at 0.5, 1 and 1.5 times
VL, using six aliquots at each spiked level, were prepared on three
different days and were independently analyzed. CCa was deter-
mined analyzing 21 blank samples fortiﬁed at VL and adding 1.64
times the standard deviation to the VL value. CCb was determined
analyzing 21 blank samples fortiﬁed at CCa concentration and
adding 1.64 times the standard deviation to the CCa value. Linearity
was performed studying the regression signiﬁcance and the line-
arity deviation of thematrix-matched calibration curves by analysis
of variance, considering a p < 0.05 as signiﬁcant. The limit of
detection was calculated by LOD ¼ 3.3 s/S, and the limit of quan-
tiﬁcation was calculated by LOQ ¼ 10 s/S, in which “s” was the
standard deviation of the linear coefﬁcient and “S” was the slope of
the calibration curves.3. Results and discussion
3.1. Optimization of sample preparation
ACN was the solvent of choice for the extraction method due to
its high efﬁciency for extracting avermectins residues from
different matrices, even in samples with high fat content (Danaher,
Howells, Crooks, Cerkvenik-Flajs, & O’Keeffe, 2006). The optimiza-
tion was performed evaluating the volume of solvent in relation to
the samples amount and varying the contact time between sample
and solvent. Both experiments were evaluated by analyte recovery
average obtained from LC-FL analysis. The inﬂuence of these two
variables on the extraction method is demonstrated in the Fig. 1. It
was observed that adding 10 mL of ACN in 5 g of sample (corre-
sponding to solvent/sample ratio of 2) showed to be more adequate
to extract all the target compounds, resulting in recoveries higher
than 90% with contact time of 10 min. It was also observed that the
increase in the organic solvent volume (eg. solvent/sample ratio of
3) does not improve the analyte recovery, but can lead to an
increase in the matrix co-extractives, which can cause analytical
problems. In addition, considering that real samples may differ in
fat content and can cause variations in the avermectins recoveries
due to the high lipophilicity of these compounds, it was deﬁned
a contact time between solvent and sample of 20 min.
The cleanup efﬁciency of LTP procedure was optimized varying
the freezing time of the extract, at 20 C. As can be seen in the
Fig. 2. Effects of freezing time on the extract cleanup and method selectivity. Legend:
Freezing time of 12 h (A) and 6 h (B) for extract of sample fortiﬁed with EPR (4.4 min),
MOX (10.8 min), ABA (18.5 min), DOR (21 min), and IVR (24 min), at VL concentrations.
EMA (16.1 min) was the surrogate standard fortiﬁed at 5 mg kg1. In (C), a characteristic
chromatogram of an extract of blank sample cleaned with 12 h of freezing time.
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interference was 12 h. It was also observed that as lower the
freezing time, higher is the presence of interfering compounds. The
result was an increase in the base line of LC-FL analysis that
hindered the correct peak integration at low concentrations
(Fig. 2B).
3.2. Validation
Commission Decision 2002/657/EC require validation around
the MRL values for authorized drugs or at concentrations as low as
possible for drugs without MRL (EC, 2002). The validation levels
used in this work were based on Codex Alimentarius and EC MRL,
and on US regulatory tolerance (USDA-FAS, 2010) because MRL forFig. 3. Chromatograms of blank and fortiﬁed samples (at concentrations corresponding to
20 mg kg1 for EPR) for selectivity and speciﬁcity assay by LC-MS/MS. Legend: Chromatogram
ion chromatogram of a blank sample.avermectins and milbemycin residues in bovine muscle was
established by the Brazilian legislation in 2011 (BRASIL, 2011).
Emamectin was selected as surrogate standard since it is an aver-
mectin licensed only for treatment of sea-lice on farmed salmon
and its presence in bovine tissues is unlikely. The surrogate stan-
dard was used in order to correct possible losses during the
analytical procedure, resulting in a satisfactory calibration curves
with no-signiﬁcant deviation from linearity (p < 0.05) in the
working range of 0e2 times VL levels, with determination coefﬁ-
cients (R2) higher than 0.99, and a signiﬁcant regression at 95%
conﬁdence level after performing analysis of variance.
The selectivity was evaluated analyzing an appropriate number
of representative blank samples and check for any interference in
and around the retention time of the target analytes. As shown in
Figs. 2C and 3, no interfering compounds were observed in both LC-
FL and LC-MS/MS methods. Speciﬁcity was determined for LC-MS/
MS, analyzing blank samples with and without avermectins addi-
tions. As can see in Fig. 3, there is a compound at 9.6 min in the two
extracted ion chromatograms of IVR. However no apparent inter-
ference was observed, since a chromatographic resolution higher
than 2 was obtained.
The proposed sample preparation result in satisfactory analyte
recovery, ranging from 88.9 to 100.7% for all analytes in three
different concentrations assessed. Method precision was satisfac-
tory with a CV% intra-day inferior of 5.4% and the CV% inter-day
lower than 8.8% for all analytes, and are in compliance with the
Commission Decision 2002/EC/657 requirements.
The analytical parameters CCa and CCb are important to esti-
mate the level of conﬁdence in the routine analytical results and are
normally used to prevent the reporting of false positive and false
negative ﬁndings, respectively (Kaufmann et al., 2011). Since these
parameters were calculated based on the relatively low standard
deviation from the precision data, values near to MRL established
by the consulted legislation were obtained. The conﬁrmation of the
identities of avermectins and milbemycin residues, in terms of
relative ion intensities, were calculated for each analyte and
compared with those limits required by the Commission Decision.
The relative ion intensities of all analytes were stable during the
validation study and were in the range from 20 to 50% of base peak,validation levels (VL) of 10 mg kg1 for ABA, IVR, and MOX, 15 mg kg1 for DOR, and
s (1) and (2) for analyte transitions according to the data shown in Table 1, (3) for total
Table 2
Summary of the calculated parameters from the validation study.
Analyte (VLa) Concentrations assessed by LC-FL Analytical limits
0.5  VL 1.0  VL 1.5  VL LC-FL LC-MS/MS
Rb (%) Intra-day
CV (%)
Inter-day
CV (%)
Rb (%) Intra-day
CV (%)
Inter-day
CV (%)
Rb (%) Intra-day
CV (%)
Inter-day
CV (%)
CCbc LDc LQc CCac CCbc
ABA (10) 95.4 3.4 6.1 99.5 3.0 3.8 100.5 0.7 3.9 11.6 0.2 0.6 14.5 19.6
DOR (15) 94.9 4.6 8.1 99.7 2.9 4.0 100.2 0.8 4.3 17.6 0.6 1.9 19.6 26.5
EPR (20) 88.9 5.4 8.0 98.5 3.0 6.1 100.2 1.9 3.9 23.9 1.1 3.4 26.6 35.7
IVR (10) 96.0 5.1 8.8 100.3 3.3 4.4 100.7 1.1 4.5 11.8 0.3 0.9 13.6 16.7
MOX (10) 95.4 0.8 5.1 97.9 2.3 3.6 99.3 1.3 2.2 11.1 0.1 0.4 14.0 17.0
a VL: validation level adopted at mg kg1.
b R (%): recovery was calculated using the average of all samples form intra and inter-day experiments.
c Concentrations in mg kg1.
Table 3
Results of the Brazilian monitoring program for avermectins and milbemycin analysis in bovine muscle samples carried out from 2010 to 2011.
Analytes LOD LOQ MRLa n < LOD LOD < n < LOQ LOQ < n < MRLa MRLa < n
ABA 0.2 0.6 10 680 72 8 0
DOR 0.6 1.9 10 711 44 5 0
EPR 1.1 3.4 100 754 6 0 0
IVR 0.3 0.9 10 601 124 35 0
MOX 0.1 0.4 20 721 26 13 0
Legend: (n) number of occurrences; (LOD), (LOQ), and (MRL) are respectively limits of detection, limits of quantiﬁcation, and maximum residue limits, expressed in mg kg1;
(n < LOD) results below the detection limits, (LOD < n < LOQ) results between detection and quantiﬁcation limits, (LOQ < n <MRL) results between quantiﬁcation limits and
MRL, and (MRL < n) results above the MRL.
a MRL values established by Brazilian legislation (BRASIL, 2011).
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dance with EU requirements. In addition, the relative retention
times of the analytes for LC-MS/MS and LC-FL analysis were below
of 1.5% from a maximum tolerance of 2.5% required as performance
criteria. Quantiﬁcation and detection limits were also calculated
and were similar to the results presented by Hou, Wu, Shen, Wang,
and Ding (2007), who reported limits of detection between 0.5 and
1.0 mg kg1 and limits of quantiﬁcation between 1.0 and 2.0 mg kg1
for avermectins in bovine tissues analyzed by LC-FL after extraction
with ACN and cleanup on a C18 cartridges. All results from vali-
dation study were presented in the Table 2.
3.3. Method application
After validation, the proposed method was applied to the
simultaneous analysis of ABA, DOR, EPR, IVR, and MOX residues in
760 real samples of bovine muscle obtained from the Brazilian
monitoring programs during 2010 and 2011. Until 100 samples per
batch were processed by only one analyst, using approximately
1000mL of ACN less than traditional extraction procedures used for
the same purpose (Chou, Lai, Chen, & Yen, 2004; Hernando, Suárez-
Barcena, Bueno, Garcia-Reyes, & Fernández-Alba, 2007; Xia et al.,
2010). The results of avermectins and milbemycin analyses are
shown in the Table 3.
Although 39.1% of the total samples analyzed presented aver-
mectins or milbemycin residues between LOD and MRL levels
(positive samples), none contained residues above the MRL estab-
lished by the Brazilian legislation. A number of them presented two
avermectins per sample, 23 samples with ABA and IVR, and 13 with
DOR and IVR, probably due to the use of associated antiparasitic
drugs. The highest concentration found was 8.9 mg kg1 of IVR. In
addition, IVR was the most common residue detected (21.0%), fol-
lowed by ABA (10.5%), DOR (6.4%), MOX (5.1%), and EPR (0.8%). The
highest occurrence of IVR residues can be related to the high
availability of this antiparasitic in the Brazilian veterinary market,
representing more than 64% of the total veterinary drugs contain-
ing avermectins (SINDAN, 2012).Recovery for QC samples, analyzed along the real samples, was
similar to the values obtained in the validation study, varying from
87 to 102%. All positive samples were conﬁrmed by LC-MS/MS
considering the 2002/657/EC criteria.4. Conclusions
Extraction of avermectins and milbemycin from bovine muscle
showed to be applicable using solideliquid extraction with low
temperature puriﬁcation. The proposed extraction method was
considered simple, easy and suitable for processing a large volume
of samples with low consumption of organic solvent. Avermectins
and milbemycin residues were quantitated and conﬁrmed by
validated LC-ﬂuorescence and LC-MS/MS methods, respectively.
The performance characteristics determined by validation study
were considered satisfactory and demonstrate the method suit-
ability for the routine analysis in the Brazilian National Residue
Control Plan. Based on the results from the Brazilian monitoring
program and on amore comprehensive auditing process conducted
by FSIS in September 2010, the resumption of meat products
exports from Brazil to US was authorized by US government in
December 2010. In addition, in December 2011, MAPA established
new criteria for the use of avermectins in cattle, restricting the use
of formulations with withdrawal time above 28 days, which
represents the average withdrawal time recommended for formu-
lations containing 1% of ivermectin.Acknowledgments
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